Epithra 50mg Injection
Rx RequiredSalt Composition: Epirubicin Hydrochloride
Expiry Date: 01/2028
Buy at $37.41
Inclusive of all taxes
1 injection
About The Product
Blood Cancer
Description
- Epithra 50mg Injection is an Anticancer injection used to treat various cancers such as blood, breast, stomach, lung, ovaries, soft tissues, colon, and rectum.
- It is also used as an adjuvant treatment for breast cancer.Epithra 50mg Injection contains epirubicin, an anthracycline antibiotic that directly kills cancer cells by targeting their DNA.
Uses
- Blood, Breast, Stomach, Lung, Ovaries, Soft Tissues, Colon, and Rectum Cancer
Side Effects
Epithra 50mg Injection is an Anticancer injection. Its salt in reaction with the body leads to numerous side effects like any other medication. Symptoms may vary from mild to severe. If these side effects remain for longer period of time, consult your doctor immediately.
- Hair loss
- Mouth Sores
- Nausea
- Weakness
- Low Red, White and Platelets Blood Cell Count
- Fluid Retention
- Muscle Pain
- Nail Change
- Fever
- Rashes
- Diarrhea
- Hot Flashes
- Gastrointestinal Inflammation
- Febrile Nutropenia
- Allergic Reactions
- Heart Damage
- Severe Bone Suppression
- Secondary Cancers
How To Use
- Epithra 50mg Injection is administered intravenously, either alone or with other cancer treatment therapies, depending on the cancer's type and stage.
- Patients should not self-administer; it must be injected by a doctor or trained nurse. Consult a doctor for precise dosage and timing.
How It Works
- Epithra 50mg Injection contains epirubicin, an anthracycline antibiotic that directly kills cancer cells by targeting their DNA.
- Epirubicin inhibits topoisomerase II, an enzyme required for DNA replication, and intercalates into DNA strands to produce complexes that prevent the production of DNA and RNA. Cancer cells die because of, this damage, which stops cell division at every stage of the cell cycle.
Safety Advice
FAQs
Epithra 50mg Injection is a chemotherapy based injection used to treat multiple cancers such as blood, breast, stomach, lung, ovaries, soft tissues, colon, and rectum.
It is also used as an adjuvant treatment for breast cancer.
References
- Conte, P. F., Gennari, A., Landucci, E., & Orlandini, C. (2000). Role of epirubicin in advanced breast cancer. Clinical breast cancer, 1, S46-S51. https://www.sciencedirect.com/science/article/abs/pii/S152682091170163X
- Plosker, G. L., & Faulds, D. (1993). Epirubicin: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in cancer chemotherapy. Drugs, 45(5), 788-856. https://pubmed.ncbi.nlm.nih.gov/7686469/
- Cersosimo, R. J., & Hong, W. K. (1986). Epirubicin: a review of the pharmacology, clinical activity, and adverse effects of an adriamycin analogue. Journal of Clinical Oncology, 4(3), 425-439. https://pubmed.ncbi.nlm.nih.gov/3005521/
- Robert, J. (1994). Clinical pharmacokinetics of epirubicin. Clinical pharmacokinetics, 26(6), 428-438.
Medical Disclaimer
Accurate, reviewed information to support informed healthcare decisions
Magicine's primary objective is to ensure that its customers receive accurate, genuine, and trustworthy information reviewed by medical experts.
The content on this website has been produced solely for informational purposes. This is not intended to take the place of medical advice and care provided by a licensed professional, though.
This information may not include all potential side effects, warnings, and details about specific lab tests, medications, and medical conditions. Please ask your doctor any questions you may have about any drug or disease.
Our goal is not to replace or substitute for the doctor-patient relationship, but to uphold and strengthen it.
.png&w=48&q=75 "Cart"){kind=small}
9655.png&w=48&q=75 "Home"){kind=small}
